Global Market Study on Recombinant Cell Culture Supplements: Increasing Clinical Research Activities in Developing Regions Aiding Market Growth


Recombinant Cell Culture Supplements  Market
  • Published On : Mar-2020 |
  • Pages : 309 Pages |
  • Format : Recombinant Cell Culture Supplements  Market Recombinant Cell Culture Supplements  Market Recombinant Cell Culture Supplements  Market Recombinant Cell Culture Supplements  Market

In recent years, biopharmaceutical companies have become increasingly dependent on contract research organizations (CROs) for their research & development operations. Clinical trials and research is now a major business in India, owing to numerous governmental-funded medical and pharmaceutical institutions with state-of-the-art facilities. India has allowed 100% Foreign Direct Investment (FDI) in clinical trials, which has attracted many companies to enter the Indian market. Research & development costs in India and China are considerably lesser as compared to those in developed countries, which will help boost the growth of the recombinant cell culture supplements market.

Increasing Demand for Animal-free Recombinant Cell Culture Supplements

Key stakeholders in the cell culture market are focusing on the introduction of animal-free recombinant cell culture supplements. Animal-free products eliminate the risk of contaminating cell culture media. They are manufactured using all human production systems or microorganisms. No animal-derived cells are used in the manufacturing of cell culture supplements. Growing adoption of animal-free products in various research applications is expected to propel the growth of the global recombinant cell culture supplements market over the coming years.

Market Players Focusing on Enhancement of Sales and Distribution Network

Strong distribution network is essential, as most players in the global recombinant cell culture supplements market have limited regional presence, and make their products available around the world using numerous retailers and distributors. Small companies in the recombinant cell culture supplements market, such as Cell Applications, Inc., have offices and manufacturing support in limited locations. However, they make their products available globally through an extensive distributor network. Roche signed an agreement with Merck for the distribution of its recombinant cell culture supplement products in 2019.

Increasing Focus on Oncological Research to Create Demand for Customized Recombinant Cell Culture Supplements

Recombinant cell culture supplements are an integral part of cancer research. The connection between recombinant growth factors and oncogenes has led to a better understanding of carcinogenesis and providing newer targets for chemotherapy. Recombinant growth factors such as vascular epithelial growth factors, epidermal growth factors, fibroblast growth factors, and platelet-driven growth factors have an important role in cancer research, For example, Hoffmann-La Roche Ltd focuses its research on cancer and other prevailing diseases such as diabetes using cell culture. The National Cancer Institute (NCI), along with other institutes, invests in major research initiatives to facilitate and support cancer research.

North America and Europe to Lead Recombinant Cell Culture Supplements Market

North America and Europe, together, hold around 65% share of the global recombinant cell culture supplements market. Increase in demand for cell culture products from biopharmaceutical companies, cancer research institutes, and others will drive the recombinant cell culture supplements market in these regions. Increasing funding for cell culture research and pipeline of biologics by major players in these regions would further drive the recombinant cell culture supplements market.

Competitive Landscape of Recombinant Cell Culture Supplements Market

Key players operating in recombinant cell culture supplements market across the globe include Thermo Fisher Scientific, Merck KGaA, Hoffmann-La Roche Ltd, Lonza Group Ltd, and FUJIFILM Holdings Corporation, among others.  Manufacturers are focusing on mergers, acquisitions, expansion, and key partnerships to expand their product portfolio and increase revenue across different geographies. For instance, in October 2018, Thermo Fisher Scientific completed the acquisition of Becton Dickinson and Company’s advanced bioprocessing business, to add cell culture products that will expand the bio-production product portfolio of the company in the recombinant cell culture supplements market. Moreover, manufacturers are focusing on expansion & advancement of production facilities to produce custom vaccines. For instance, in August 2016, Merck opened a new pharmaceutical manufacturing plant in Nantong, China. This strategic investment further supports Merck’s expansion in the global recombinant cell culture supplements market.

Analysts’ Viewpoint

The research report on the recombinant cell culture supplements market provides recommendations, overview of the market, and estimation of market growth over the next decade. Increment in the number of biopharmaceutical manufacturers and increasing life research investments are responsible for the growth of the recombinant cell culture supplements market. Increasing prevalence of diseases such as cancer and diabetes, across the world, and development of novel biologics will favor the growth of the global recombinant cell culture supplements market in the years to come.

Recombinant Cell Culture Supplements Market - Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for recombinant cell culture supplements market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the recombinant cell culture supplements market structure. The market study presents exclusive information about how the recombinant cell culture supplements market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR), are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis by region and by product, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors This information can help readers understand the quantitative growth prospects of the recombinant cell culture supplements market for the forecast period.

The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to the macroeconomic factors that are impacting the developments in the market. It also offers actionable insights based on the future trends in the recombinant cell culture supplements market. Furthermore, small businesses and new entrants in the recombinant cell culture supplements market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Segments of Recombinant Cell Culture Supplements Market

PMR’s study on the recombinant cell culture supplements market offers information divided into five important segments—product, end user, source, application, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Application

End User

Source

Product

Region

  • Stem Cell Therapy
  • Gene Therapy
  • Bioprocess Application
  • Vaccine Development
  • Others
  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Cancer Research Centers
  • Contract Research Centers (CROs)
  • Animals
  • Microorganisms
  • Human
  • Recombinant Growth Factors
    • Transforming Growth Factors
    • Epidermal Growth Factors
    • Platelet-derived Growth Factors
    • Fibroblast Growth Factors
    • Vascular Endothelial Growth Factors (VEGFs)
    • Interleukins 
    • Recombinant Stem Cell Factors
    • Other Growth Factors
  • Recombinant Insulin
  • Recombinant Albumin
  • Recombinant Transferrin
  • Recombinant Trypsin
  • Recombinant Aprotinin
  • Recombinant Lysozyme
  • Others
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in PMR’s Recombinant Cell Culture Supplements Market Report

  • Which regions will continue to remain the most profitable regional markets for recombinant cell culture supplement market players?
  • Which factors will induce a change in the demand for recombinant cell culture supplements during the assessment period?
  • What are the different opportunities available for emerging players in the recombinant cell culture supplements market?
  • How are supply-side and demand-side drivers impacting the recombinant cell culture supplements market?
  • How will changing trends impact the recombinant cell culture supplements market?
  • How can market players capture the low-hanging opportunities in the recombinant cell culture supplements market in developed regions?
  • Which companies are leading the recombinant cell culture supplements market?
  • What are the winning strategies of stakeholders in the recombinant cell culture supplements market to upscale their position in this landscape?

Recombinant Cell Culture Supplements Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the recombinant cell culture supplements market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the recombinant cell culture supplements market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the recombinant cell culture supplements market, and makes PMR’s projections on the growth prospects of the recombinant cell culture supplements market more accurate and reliable.

Companies covered in Recombinant Cell Culture Supplements Market Report

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza Group AG
  • F. Hoffmann-La Roche AG
  • Abcam PLC.
  • Hi-Media Laboratories
  • Becton, Dickinson and Company
  • STEMCELL Technologies Inc.
  • Fujifilm Corporation (Irvine Scientific)
  • InVitria (Ventria Bioscience)
  • Biocon
  • Cell Sciences, Inc.

Recombinant Cell Culture Supplements Market

Back To Top